An2 Therapeutics, Inc. · NASDAQ:ANTX
Coastlands Capital LP reported a 9.30% stake in An2 Therapeutics, Inc. (Schedule 13G)
Event May 28, 2025 · Filed Jun 4, 2025
Coastlands Capital LP reported a 9.30% stake in An2 Therapeutics, Inc., 2,815,900 shares, as a passive investor on May 28, 2025. Filed Jun 4, 2025 (Schedule 13G).
- Stake
- 9.30%
- Shares
- 2,815,900
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Coastlands Capital LP | 9.30% | 2,815,900 |
| Coastlands Capital Partners LP | 9.30% | 2,815,900 |
| Coastlands Capital GP LLC | 9.30% | 2,815,900 |
| Coastlands Capital LLC | 9.30% | 2,815,900 |
| Matthew D. Perry | 9.30% | 2,815,900 |